A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)
Public ClinicalTrials.gov record NCT03781167. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A 52-Week, Open-label, Single-arm Study to Evaluate the Safety and Tolerability of 24-hour Daily Exposure of Continuous Subcutaneous Infusion of ABBV-951 in Subjects With Parkinson's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study was to assess the safety and tolerability of ABBV-951 (Foslevodopa/Foscarbidopa) in participants with Parkinson's disease (PD). This was a single-arm study with preplanned analyses conducted by dose subgroup (Low Dose or High Dose) based on the modal total daily dose (most frequent dose) over the treatment period.
Study identification
- NCT ID
- NCT03781167
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 244 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 30 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 28, 2019
- Primary completion
- Aug 16, 2022
- Completion
- Aug 16, 2022
- Last update posted
- Oct 22, 2023
2019 – 2022
United States locations
- U.S. sites
- 24
- U.S. states
- 19
- U.S. cities
- 24
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham - Main /ID# 207996 | Birmingham | Alabama | 35233 | — |
| Banner Sun Health Res Inst /ID# 208811 | Sun City | Arizona | 85351 | — |
| The Parkinson's & Movement Disorder Institute - Fountain Valley /ID# 216126 | Fountain Valley | California | 92708 | — |
| University of Colorado Hospital /ID# 207968 | Aurora | Colorado | 80045 | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton /ID# 207677 | Boca Raton | Florida | 33486 | — |
| Northwestern University Feinberg School of Medicine /ID# 208812 | Chicago | Illinois | 60611-2927 | — |
| Indiana Clinical Research Cent /ID# 207952 | Indianapolis | Indiana | 46202 | — |
| Univ Kansas Med Ctr /ID# 208963 | Kansas City | Kansas | 66160 | — |
| University of Kentucky Chandler Medical Center /ID# 207603 | Lexington | Kentucky | 40536 | — |
| Massachusetts General Hospital /ID# 207993 | Boston | Massachusetts | 02114 | — |
| Health Partners /ID# 207950 | Saint Paul | Minnesota | 55130-2400 | — |
| University of Missouri /ID# 209043 | Columbia | Missouri | 65203 | — |
| Washington University-School of Medicine /ID# 207525 | St Louis | Missouri | 63110 | — |
| Dartmouth-Hitchcock Medical Center /ID# 207972 | Lebanon | New Hampshire | 03756 | — |
| Wake Radiology UNC REX Healthcare - Raleigh Office /ID# 209784 | Raleigh | North Carolina | 27612 | — |
| Legacy Medical Group - Neurology /ID# 208031 | Portland | Oregon | 97232-2003 | — |
| Prisma Health Cancer Institute-Faris Road /ID# 207650 | Greenville | South Carolina | 29605-4255 | — |
| Neurology Consultants of Dallas - LBJ Fwy /ID# 207619 | Dallas | Texas | 75243-1188 | — |
| Baylor College of Medicine /ID# 207620 | Houston | Texas | 77030-4202 | — |
| Central Texas Neurology Consul /ID# 216918 | Round Rock | Texas | 78681 | — |
| Univ Texas HSC San Antonio /ID# 208958 | San Antonio | Texas | 78229-3901 | — |
| Booth Gardner Parkinson's Care Center /ID# 208026 | Kirkland | Washington | 98034-3029 | — |
| Inland Northwest Research /ID# 208122 | Spokane | Washington | 99202-1342 | — |
| Medical College of Wisconsin /ID# 207999 | Milwaukee | Wisconsin | 53226-3522 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 41 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03781167, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 22, 2023 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03781167 live on ClinicalTrials.gov.